CASE REPORT
Published on 26 Jun 2025
Case Report: dose adjustment of orelabrutinib for managing central nervous system post-transplant lymphoproliferative disorder following acute lymphoblastic leukemia transplantation
doi 10.3389/fimmu.2025.1597119
- 466 views